Search

Your search keyword '"Pamela A. Hershberger"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Pamela A. Hershberger" Remove constraint Author: "Pamela A. Hershberger" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
16 results on '"Pamela A. Hershberger"'

Search Results

1. Data from Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model

2. Supplementary Table 1 from Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model

Catalog

Books, media, physical & digital resources

3. Data from Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer

4. Supplementary Figures 1 through 4 from Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer

6. Abstract 1093: BRD9 inhibition overcomes epithelial to mesenchymal transition (EMT)-associated tyrosine kinase inhibitor (TKI) tolerance in epidermal growth factor receptor (EGFR) mutant lung cancer

7. Abstract PO-061: Deciphering radiation resistance in head and neck cancer using patient derived organoids

8. Abstract A22: Patient-derived organoids recapitulate response heterogeneity in head and neck cancer

9. Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model

10. Regulation of Endogenous Gene Expression in Human Non–Small Cell Lung Cancer Cells by Estrogen Receptor Ligands

11. Abstract 4674: Vitamin D enhances erlotinib response in EGFR-mutant non-small cell lung cancer

12. Abstract 4751: 25-hydroxyvitamin D3 induces vitamin D signaling independent of CYP27B1 in non-small cell lung cancer cells

13. Abstract 238: Vitamin D sufficiency slows the progression of dysplasic lesions in the NTCU mouse model of lung squamous cell carcinoma

14. Abstract 5499: Temozolomide (TMZ) cytotoxicity in human melanoma cell lines is enhanced by concomitant treatment with the histone deacetylase (HDAC) inhibitor vorinostat (SAHA) and PARP inhibitor MK-4827

15. Abstract 4549: Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice

16. Abstract 4973: C/EBPβ increases expression of the vitamin D3 catabolizing enzyme, CYP24, in non-small cell lung cancer cells